ViiV Healthcare
FDA Grants New Indication for Dovato to Treat Adolescents 12 and Older
The FDA granted a new indication for Dovato to treat HIV-1 infection in adolescents 12 years of age and older and ...
APRIL 8, 2024
New Fellowship to Improve HIV Prevention in Key Communities Available
A new fellowship—The Dr. Dawn K. Smith HIV Prevention Clinical Fellowship—to provide comprehensive HIV ...
MARCH 18, 2024
FDA Grants New Indication for Cabenuva for Every-8–Week Dosing
The FDA extended the time between shots of Cabenuva to every two months to treat HIV-1 infection in virologically ...
FEBRUARY 1, 2022
FDA Approves Cabenuva Long-Acting HIV Treatment
cabotegravir plus rilpivirine is dosed once monthly as an option to replace a patient’s current ...
JANUARY 22, 2021
Fostemsavir Bright Spot in Improving Virologic Suppression in Resistant HIV Patients
Rates of virologic suppression and immunologic response increased from weeks 48 to 96 in a phase 3 clinical trial ...
JULY 25, 2019
FDA Approves Dovato—First 2-Drug Complete Regimen for HIV
Dovato is a single table regimen containingdolutegravir-lamivudine and is approved as a complete regimen for the ...
APRIL 8, 2019
Dolutegravir Maintains Virologic Suppression in Multiple Trials
Dolutegravir-based regimens provide long-term suppression in HIV patients, according to presentations at the 22nd ...
JULY 26, 2018
Switching HIV Regimen Found Safe
Switching to the newly approved Biktarvy in virologically suppressed adults maintained viral suppression with fewer ...
MARCH 7, 2018
ViiV Files Suit Against Gilead Over HIV Drug Patents
ViiV claims bictegravir infringes on its patent covering dolutegravir and many other compounds that include ...
FEBRUARY 8, 2018
FDA Approves Juluca, First 2-Drug Regimen for HIV
Juluca is the first complete treatment regimen containing only two drugs for the maintenance treatment of HIV-1 ...
NOVEMBER 22, 2017
Bictegravir-Containing Compound Looks Promising for HIV
Bictegravir is a novel, potent integrase strand transfer inhibitor (INSTI), which features a high in vitro barrier ...
OCTOBER 10, 2017
